AKT1 and cancer: We illustrate how cancer cells exploit the canonical FKBP51 to foster signaling networks, as, for example, NF-κB, Akt, and TGF-β that support tumor intrinsic properties and the spliced FKBP51s to gain the capacity to evade the immune system.